TRIM37 controls cancer-specific vulnerability to PLK4 inhibition. Meitinger F, Ohta M, Lee KY, Watanabe S, et al. Nature 2020;585:440-446.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Meitinger F, Ohta M, Lee KY, Watanabe S, et al. TRIM37 controls cancer-specific vulnerability to PLK4 inhibition. Nature 2020;585:440-446.
PMID: 32908304